<< Previous Page Displaying 25 through 32 of 41 Next Page >>
|
| The Parkinson's Institute and El Camino Hospital join Parkinson's Progression Markers Initiative (PPMI) as offical study site |
| Tuesday, September 28, 2010 |
| SUNNYVALE, Calif., September 28, 2010 — The Parkinson’s Institute, in conjunction with El Camino Hospital announced that it is one of 18 official study sites for the Parkinson’s Progression Markers Initiative (PPMI), a landmark observational clinical study sponsored by The Michael J. Fox Foundation, which will use a combination of advanced imaging, |
| |
| Stem Cell Tourism Update |
| Monday, July 26, 2010 |
| One of the most frequent questions we have is where patients can receive stem cell treatments and how effective they are for treating or curing Parkinson’s. |
| |
| Guideline Issued for Treating Sleep, Constipation, Sexual Problems in Parkinson’s Disease |
| Wednesday, March 24, 2010 |
| ST. PAUL, Minn. – The American Academy of Neurology has issued a new guideline recommending the most effective treatments to help people with Parkinson’s disease who experience sleep, constipation, and sexual problems, which are common but often underrecognized symptoms. The guideline is published in the March 16, 2010, issue of Neurology®, the medical |
| |
| MJFF Awards $2.8 Million to Drive Development of Parkinson's Disease Biomarker Pipeline |
| Friday, February 12, 2010 |
| The Michael J. Fox Foundation for Parkinson’s Research today announced more than $2.8 million in awards for 13 new projects to speed the discovery of biomarkers of PD. The development of biomarkers is of critical importance to increasing the speed and efficiency of PD therapeutic development, allowing scientists and clinicians to more accurately identify |
| |
| Industrial Cleaner Linked to Increased Risk of Parkinson’s Disease |
| Tuesday, February 9, 2010 |
| Sunnyvale, CA – February 8, 2010
The Parkinson’s Institute and Clinical Center (PI) is excited to announce the publication of the report, "Parkinson’s Disease Risk is Increased in Discordant Twins Exposed to Specific Solvents" by The American Academy of Neurology. Samuel M. Goldman, MD, MPH and colleagues at the Parkinson’s Institute in Sunnyvale found |
| |
| Agent Orange Component Linked to Parkinson’s Disease |
| Monday, September 14, 2009 |
Workplace use of the herbicide
2,4-dichlorophenoxyacetic acid (2,4-D), a key constituent of the
defoliant Agent Orange, is associated with an increased risk of
developing Parkinson’s disease, according to a report published in the
Archives of Neurology by Caroline M. Tanner, M.D., Ph.D., Director of
Clinical Research at the Parkinson’s Institute, and her colleagues at
eight Parkinson’s disease research centers in the U.S. and Canada. Two
other pesticides – paraquat and permethrin – were also associated with
higher risk of Parkinson’s disease. |
| |
| Genetics Research Project Launched |
| Friday, March 13, 2009 |
| 23andMe, Inc., an industry leader in personal genetics, announced today that it has launched a Parkinson’s disease initiative in collaboration with the Parkinson’s Institute and Clinical Center (“PI”) and The Michael J. Fox Foundation (“MJFF”). Press Release
|
| |
| Dr.J. William Langston Awarded 2008 Donald Calne Lectureship |
| Friday, January 9, 2009 |
| The Parkinson’s Institute and Clinical Center, (PI) is, is very excited to announce Dr. J. William Langston has been awarded the sixth annual Donald Calne Lectureship awarded by the Parkinson Society of Canada.
|
| |
<< Previous Page Next Page >>
|
